Jerry Robben
Optometrist · St Augustine, FLNPI 1528376589
Payments from drug & device makers
Across 612 payments — averaging $1083.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch Health US, LLC$181K
- Alcon Research LLC$137K
- AbbVie$135K
- Kala Pharmaceuticals, Inc.$53K
- Bausch & Lomb Americas Inc.$38K
- Oyster Point Pharma, Inc.$38K
- plus $80K from 25 others
Across 2 payments — averaging $1912.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$4K
What the payments were for
- Consulting fees$37,79820%
- Speaking & faculty fees$108,58557%
- Grants$1,0431%
- Travel & lodging$26,32114%
- Food & beverage$15,4438%
- Education$4830%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch Health US, LLC | 24 | $181,129 |
| Alcon Research LLC | 2 | $136,894 |
| AbbVie(2 entities) | 164 | $135,063 |
| Kala Pharmaceuticals, Inc. | 53 | $53,467 |
| Bausch & Lomb Americas Inc. | 58 | $38,435 |
| Oyster Point Pharma, Inc. | 49 | $37,587 |
| Sun Pharmaceutical Industries Inc. | 65 | $17,024 |
| Eyevance Pharmaceuticals LLC | 28 | $14,636 |
| Biotissue Holdings Inc. | 23 | $13,390 |
| Johnson & Johnson Vision Care, Inc. | 4 | $8,993 |
| Johnson & Johnson Surgical Vision, Inc. | 16 | $7,534 |
| Shire North American Group Inc | 10 | $5,100 |
| Dompe Farmaceutici S.p.a. | 9 | $3,580 |
| Tarsus Pharmaceuticals, Inc. | 13 | $2,334 |
| The Walman Optical Company | 1 | $2,250 |
| Alcon | 19 | $2,089 |
| Sight Sciences, Inc. | 4 | $1,275 |
| Quidel Corporation | 6 | $346 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 11 | $324 |
| Novartis | 15 | $317 |
| Dompe US, Inc. | 3 | $275 |
| Harrow Eye, LLC | 11 | $250 |
| Aerie Pharmaceuticals, Inc. | 6 | $151 |
| Tearlab Corp | 1 | $147 |
| Coopervision Inc. | 3 | $114 |
| Thea Pharma Inc. | 2 | $112 |
| Amgen(2 entities) | 5 | $108 |
| Rxsight Inc | 3 | $61 |
| Ocular Therapeutix, Inc. | 2 | $37 |
| Plexus Optix, Inc. | 1 | $22 |
| Glaukos Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MIEBO$32,795
- XIIDRA$27,892
- TYRVAYA$18,213
- CEQUA$15,862
- VUITY$15,555
- RESTASIS$11,257
- EYSUVIS$10,222
- LUMIGAN$9,600
- Flarex$7,872
- Prokera$5,398
- AmnioGraft$5,398
- Zerviate$5,366
- LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE)$5,200
- RESTASIS MULTIDOSE$4,977
- DURYSTA$4,060
- COMBIGAN$3,600
- TearScience Activators$1,980
- TearScience Lipiflow System$1,980
- TearScience Lipiscan System$1,980
- TearScience Lipiview System$1,980
How this compares
$663,059 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 89 | $105,935 |
| LumiganBimatoprost | 85 | $39,769 |
| XdemvyLotilaner | 18 | $34,451 |
| MieboPerfluorohexyloctane/Pf | 41 | $32,606 |
| TyrvayaVarenicline Tartrate | 20 | $17,173 |
| XiidraLifitegrast | 13 | $13,910 |
| Cyclosporine | 20 | $9,859 |
| RhopressaNetarsudil Mesylate | 14 | $7,034 |
| CombiganBrimonidine Tartrate/Timolol | 13 | $6,989 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 25 | $4,971 |
| RocklatanNetarsudil Mesylat/Latanoprost | 12 | $4,465 |
| Loteprednol Etabonate | 31 | $4,386 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 13 | $3,581 |
| Prednisolone Acetate | 50 | $2,683 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 26 | $1,352 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan | $135,063 | $152,693187 claims |
| Bausch & Lomb Americas Inc.Miebo, Xiidra | $38,435 | $46,51654 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $2,334 | $34,45118 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $37,587 | $17,17320 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $151 | $11,49926 claims |
| AlconSimbrinza | $2,089 | $4,97125 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $324 | $4,38631 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,166 optometrist providers in Florida.
Other optometrist in St Augustine
- Diane KapadiaSt Augustine$181K
- Michael KynnJacksonville$4.5M
- Christine HalodaJacksonville$3.1M
- Bradley GieddWinter Park$2.5M
- Christopher PearsonLongwood$2.5M
- Mark PerryOrlando$1.6M
- Bryan StamJacksonville Beach$1M
- Oksana SovaJacksonville$841K
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$781K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.